The A’s hosted their annual FanFest today with a sellout crowd of over 15,000. Here are the highlights:
- The A’s experienced plenty of turnover this offseason (nine trades involving 27 players) and the holdovers are starting to see the method in GM Billy Beane’s madness. “Initially when the trades are going on, you’re going, ’Come on, seriously? Another All-Star caliber player is leaving us?’” said Coco Crisp (as quoted by Susan Slusser of the San Francisco Chronicle). “But as things progressed, I started to see things come together, and I understand it from a business standpoint and for the future. Some of the players we got have the potential to be great players and we have another team out to prove ourselves. I think it’s going to work out good.“
- Also from Slusser, Beane has a plan if his offseason maneuvers don’t work. “If one of these (trades) doesn’t work, we’ll make another one because that’s what we do. We’re not going to wait around.“
- Beane apparently isn’t waiting around for James Shields. Slusser has heard rumblings the A’s might be one of the teams still in play for Shields, but she has been assured they are not.
- MLB.com’s Jane Lee updated the status of a trio of injured pitchers in a pair of reports. Sean Doolittle received a platelet-rich plasma (PRP) injection to alleviate inflammation and irritation in his left shoulder. “Everything so far has gone really smoothly,” Doolittle said. “We’re optimistic, but we haven’t set a timetable because, based on what the doctors and trainers have said, every issue is kind of different. With PRP, it’s all about how your body reacts to it.” Doolittle has entered the beginning stages of a strengthening program, but manager Bob Melvin admits there is a good chance his closer will miss the early part of the season.
- A’s Assistant GM David Forst and Melvin both reiterated the probable timetable for starters Jarrod Parker and A.J. Griffin to return is June, barring any setbacks from their Tommy John surgeries.
- Slusser reports the A’s continue to monitor Cuban infielders Yoan Moncada and Hector Olivera, but doubts the team has the payroll for Moncada having never spent more than $66MM on a player and does not see Olivera receiving an offer greater than the four-year, $36MM deal signed by Yoenis Cespedes.
